FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:AAK1-LHX2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: AAK1-LHX2
FusionPDB ID: 62
FusionGDB2.0 ID: 62
HgeneTgene
Gene symbol

AAK1

LHX2

Gene ID

112268437

9355

Gene nameuncharacterized protein FLJ45252LIM homeobox 2
SynonymsAAK1LH2|hLhx2
Cytomap

-

9q33.3

Type of geneprotein-codingprotein-coding
Descriptionuncharacterized protein FLJ45252alternative protein AAK1LIM/homeobox protein Lhx2LIM HOX gene 2LIM homeobox protein 2homeobox protein LH-2
Modification date2020030320200313
UniProtAcc

Q2M2I8

Main function of 5'-partner protein: FUNCTION: Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:17494869, PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124). {ECO:0000269|PubMed:11877457, ECO:0000269|PubMed:11877461, ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:14617351, ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124, ECO:0000269|PubMed:25653444}.; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. {ECO:0000269|PubMed:25653444, ECO:0000305|PubMed:31136173}.

P50458

Main function of 5'-partner protein: FUNCTION: Acts as a transcriptional activator. Stimulates the promoter of the alpha-glycoprotein gene. Transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000406297, ENST00000409068, 
ENST00000409085, ENST00000470281, 
ENST00000373615, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score19 X 13 X 11=27174 X 2 X 4=32
# samples 224
** MAII scorelog2(22/2717*10)=-3.62643913669732
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/32*10)=0.321928094887362
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: AAK1 [Title/Abstract] AND LHX2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: AAK1 [Title/Abstract] AND LHX2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AAK1(69783992)-LHX2(126776240), # samples:1
Anticipated loss of major functional domain due to fusion event.AAK1-LHX2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-LHX2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-LHX2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-LHX2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:69783992/chr9:126776240)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across AAK1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across LHX2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000409068AAK1chr269783992-ENST00000373615LHX2chr9126776240+22915962151696493
ENST00000409085AAK1chr269783992-ENST00000373615LHX2chr9126776240+23546592781759493
ENST00000406297AAK1chr269783992-ENST00000373615LHX2chr9126776240+23546592781759493

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000409068ENST00000373615AAK1chr269783992-LHX2chr9126776240+0.0098385940.9901614
ENST00000409085ENST00000373615AAK1chr269783992-LHX2chr9126776240+0.0114337590.9885662
ENST00000406297ENST00000373615AAK1chr269783992-LHX2chr9126776240+0.0114337590.9885662

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for AAK1-LHX2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
AAK1chr269783992LHX2chr9126776240596127HDLQVCKREIQIMTMPSISSDRAALC
AAK1chr269783992LHX2chr9126776240659127HDLQVCKREIQIMTMPSISSDRAALC

Top

Potential FusionNeoAntigen Information of AAK1-LHX2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-LHX2_69783992_126776240.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-LHX2chr269783992chr9126776240659HLA-B47:01REIQIMTM0.99840.5561715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:01REIQIMTM0.98490.9331715
AAK1-LHX2chr269783992chr9126776240659HLA-B39:13REIQIMTM0.95840.9458715
AAK1-LHX2chr269783992chr9126776240659HLA-B45:01REIQIMTMP0.99530.8143716
AAK1-LHX2chr269783992chr9126776240659HLA-B27:04KREIQIMTM0.99420.7404615
AAK1-LHX2chr269783992chr9126776240659HLA-B50:02REIQIMTMP0.99350.5197716
AAK1-LHX2chr269783992chr9126776240659HLA-B27:05KREIQIMTM0.98650.8311615
AAK1-LHX2chr269783992chr9126776240659HLA-A02:21IQIMTMPSI0.93760.5978918
AAK1-LHX2chr269783992chr9126776240659HLA-B13:02IQIMTMPSI0.91520.6331918
AAK1-LHX2chr269783992chr9126776240659HLA-B13:01IQIMTMPSI0.82530.9435918
AAK1-LHX2chr269783992chr9126776240659HLA-B41:01REIQIMTMP0.58190.8719716
AAK1-LHX2chr269783992chr9126776240659HLA-B52:01IQIMTMPSI0.48360.9389918
AAK1-LHX2chr269783992chr9126776240659HLA-B50:01REIQIMTMP0.31440.8049716
AAK1-LHX2chr269783992chr9126776240659HLA-B40:06REIQIMTM0.99970.7034715
AAK1-LHX2chr269783992chr9126776240659HLA-B39:08REIQIMTM0.97490.7856715
AAK1-LHX2chr269783992chr9126776240659HLA-B40:06REIQIMTMP0.99690.7034716
AAK1-LHX2chr269783992chr9126776240659HLA-C07:95KREIQIMTM0.99570.7412615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:27KREIQIMTM0.99520.9695615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:05KREIQIMTM0.99120.9692615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:29KREIQIMTM0.990.9458615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:13KREIQIMTM0.98990.9259615
AAK1-LHX2chr269783992chr9126776240659HLA-B27:14KREIQIMTM0.98890.6776615
AAK1-LHX2chr269783992chr9126776240659HLA-B39:12KREIQIMTM0.98810.8791615
AAK1-LHX2chr269783992chr9126776240659HLA-B15:04IQIMTMPSI0.93950.8976918
AAK1-LHX2chr269783992chr9126776240659HLA-C07:46KREIQIMTM0.91280.9369615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:19KREIQIMTM0.90190.8553615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:80KREIQIMTM0.90150.9679615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:67KREIQIMTM0.90150.9679615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:10KREIQIMTM0.87420.9773615
AAK1-LHX2chr269783992chr9126776240659HLA-B27:03KREIQIMTM0.84450.8469615
AAK1-LHX2chr269783992chr9126776240659HLA-B14:03KREIQIMTM0.58020.6005615
AAK1-LHX2chr269783992chr9126776240659HLA-B51:07IQIMTMPSI0.41450.788918
AAK1-LHX2chr269783992chr9126776240659HLA-C12:16KREIQIMTM0.1660.9423615
AAK1-LHX2chr269783992chr9126776240659HLA-B40:04REIQIMTM0.99910.6954715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:11REIQIMTM0.99770.9477715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:08REIQIMTM0.98640.9014715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:06REIQIMTM0.98630.9396715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:05REIQIMTM0.98490.9331715
AAK1-LHX2chr269783992chr9126776240659HLA-B18:03REIQIMTM0.98460.9248715
AAK1-LHX2chr269783992chr9126776240659HLA-B39:02REIQIMTM0.95090.9426715
AAK1-LHX2chr269783992chr9126776240659HLA-B41:03REIQIMTM0.91780.592715
AAK1-LHX2chr269783992chr9126776240659HLA-B15:53REIQIMTM0.90060.9613715
AAK1-LHX2chr269783992chr9126776240659HLA-B48:02REIQIMTM0.83680.9562715
AAK1-LHX2chr269783992chr9126776240659HLA-B27:06KREIQIMTM0.99880.7363615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:01KREIQIMTM0.99660.7701615
AAK1-LHX2chr269783992chr9126776240659HLA-B27:10KREIQIMTM0.99280.8956615
AAK1-LHX2chr269783992chr9126776240659HLA-B39:31KREIQIMTM0.98890.8717615
AAK1-LHX2chr269783992chr9126776240659HLA-B27:08KREIQIMTM0.98590.6753615
AAK1-LHX2chr269783992chr9126776240659HLA-B15:73IQIMTMPSI0.97140.9341918
AAK1-LHX2chr269783992chr9126776240659HLA-B27:09KREIQIMTM0.96560.7773615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:17KREIQIMTM0.94320.9692615
AAK1-LHX2chr269783992chr9126776240659HLA-A02:06IQIMTMPSI0.93760.5978918
AAK1-LHX2chr269783992chr9126776240659HLA-B15:30IQIMTMPSI0.9360.8999918
AAK1-LHX2chr269783992chr9126776240659HLA-C07:02KREIQIMTM0.90150.9679615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:04KREIQIMTM0.86690.8982615
AAK1-LHX2chr269783992chr9126776240659HLA-C07:22KREIQIMTM0.78190.6488615
AAK1-LHX2chr269783992chr9126776240659HLA-C06:08KREIQIMTM0.73150.9914615
AAK1-LHX2chr269783992chr9126776240659HLA-C06:06KREIQIMTM0.61910.9804615
AAK1-LHX2chr269783992chr9126776240659HLA-B50:04REIQIMTMP0.31440.8049716
AAK1-LHX2chr269783992chr9126776240659HLA-B50:05REIQIMTMP0.31440.8049716
AAK1-LHX2chr269783992chr9126776240659HLA-C06:17KREIQIMTM0.22410.9939615
AAK1-LHX2chr269783992chr9126776240659HLA-C06:02KREIQIMTM0.22410.9939615

Top

Potential FusionNeoAntigen Information of AAK1-LHX2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-LHX2_69783992_126776240.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-LHX2chr269783992chr9126776240659DRB1-0102EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0123EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0401EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0403EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0403REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0413EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0413REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0415EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0415REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0419EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0419REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0427EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0427REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0431EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0431REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0433EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0435EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0436EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0436REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0437EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0437REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0438EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0439EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0439REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0440EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0440REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0440KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0441EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0441REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0442EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0442REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0442KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0443EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0443REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0444EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0444REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0444KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0444IQIMTMPSISSDRAA924
AAK1-LHX2chr269783992chr9126776240659DRB1-0446EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0446REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0447EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0449EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0449REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0450EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0450REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0451EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0451REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0452EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0452REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0453EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0453REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0453KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0453IQIMTMPSISSDRAA924
AAK1-LHX2chr269783992chr9126776240659DRB1-0454EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0455EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0455REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0456EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0456REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0456KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0456IQIMTMPSISSDRAA924
AAK1-LHX2chr269783992chr9126776240659DRB1-0458EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0458REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0459EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0459REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0460EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0460REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0461EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0461REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0463EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0465EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0465REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0468EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0468REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0468KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0470EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0470REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0470KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0470IQIMTMPSISSDRAA924
AAK1-LHX2chr269783992chr9126776240659DRB1-0471EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0471REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0473EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0473REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0475EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0475REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0476EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0478EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0478REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0479EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0479REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0479KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-0479IQIMTMPSISSDRAA924
AAK1-LHX2chr269783992chr9126776240659DRB1-0485EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0485REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-0488EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-0488REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1002EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1002REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1201KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1201CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1203KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1203CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1203REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1204KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1204EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1204REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1205KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1205CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1206KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1206CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1207KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1207CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1208KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1208CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1209KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1209EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1209REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1210KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1210CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1211KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1211CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1212KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1212CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1213KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1213CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1214KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1214CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1215KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1215CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1216KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1217KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1217CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1218KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1218CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1219KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1219CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1220KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1221KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1221REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1221CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1222KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1222CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1223KREIQIMTMPSISSD621
AAK1-LHX2chr269783992chr9126776240659DRB1-1223CKREIQIMTMPSISS520
AAK1-LHX2chr269783992chr9126776240659DRB1-1452EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1452REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB1-1457EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1615EIQIMTMPSISSDRA823
AAK1-LHX2chr269783992chr9126776240659DRB1-1615REIQIMTMPSISSDR722
AAK1-LHX2chr269783992chr9126776240659DRB5-0205EIQIMTMPSISSDRA823

Top

Fusion breakpoint peptide structures of AAK1-LHX2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4553KREIQIMTMPSISSAAK1LHX2chr269783992chr9126776240659

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of AAK1-LHX2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4553KREIQIMTMPSISS-7.9962-8.1096
HLA-B14:023BVN4553KREIQIMTMPSISS-5.70842-6.74372
HLA-B52:013W394553KREIQIMTMPSISS-6.83737-6.95077
HLA-B52:013W394553KREIQIMTMPSISS-4.4836-5.5189
HLA-A11:014UQ24553KREIQIMTMPSISS-10.0067-10.1201
HLA-A11:014UQ24553KREIQIMTMPSISS-9.03915-10.0745
HLA-A24:025HGA4553KREIQIMTMPSISS-6.56204-6.67544
HLA-A24:025HGA4553KREIQIMTMPSISS-5.42271-6.45801
HLA-B44:053DX84553KREIQIMTMPSISS-7.85648-8.89178
HLA-B44:053DX84553KREIQIMTMPSISS-5.3978-5.5112
HLA-A02:016TDR4553KREIQIMTMPSISS-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of AAK1-LHX2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
AAK1-LHX2chr269783992chr9126776240615KREIQIMTMAAGAGAGAAATCCAGATAATGACCATG
AAK1-LHX2chr269783992chr9126776240715REIQIMTMAGAGAAATCCAGATAATGACCATG
AAK1-LHX2chr269783992chr9126776240716REIQIMTMPAGAGAAATCCAGATAATGACCATGCCG
AAK1-LHX2chr269783992chr9126776240918IQIMTMPSIATCCAGATAATGACCATGCCGTCCATC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
AAK1-LHX2chr269783992chr9126776240520CKREIQIMTMPSISSTGCAAGAGAGAAATCCAGATAATGACCATGCCGTCCATCAGCAGT
AAK1-LHX2chr269783992chr9126776240621KREIQIMTMPSISSDAAGAGAGAAATCCAGATAATGACCATGCCGTCCATCAGCAGTGAC
AAK1-LHX2chr269783992chr9126776240722REIQIMTMPSISSDRAGAGAAATCCAGATAATGACCATGCCGTCCATCAGCAGTGACCGC
AAK1-LHX2chr269783992chr9126776240823EIQIMTMPSISSDRAGAAATCCAGATAATGACCATGCCGTCCATCAGCAGTGACCGCGCC
AAK1-LHX2chr269783992chr9126776240924IQIMTMPSISSDRAAATCCAGATAATGACCATGCCGTCCATCAGCAGTGACCGCGCCGCG

Top

Information of the samples that have these potential fusion neoantigens of AAK1-LHX2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCSAAK1-LHX2chr269783992ENST00000406297chr9126776240ENST00000373615TCGA-N5-A59F-01A

Top

Potential target of CAR-T therapy development for AAK1-LHX2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to AAK1-LHX2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to AAK1-LHX2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource